These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 22075063)

  • 1. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
    Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in glucocorticoid-naïve large-vessel vasculitis.
    Pazzola G; Padovano I; Boiardi L; Versari A; Pipitone N; Catanoso M; Pulsatelli L; Meliconi R; Salvarani C
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S59-61. PubMed ID: 23306184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
    Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
    Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
    Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab for the treatment of patients with refractory Takayasu arteritis.
    Nakaoka Y; Higuchi K; Arita Y; Otsuki M; Yamamoto K; Hashimoto-Kataoka T; Yasui T; Ikeoka K; Ohtani T; Sakata Y; Shima Y; Kumanogoh A; Yamauchi-Takihara K; Tanaka T; Kishimoto T; Komuro I
    Int Heart J; 2013; 54(6):405-11. PubMed ID: 24309452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab, an effective treatment for relapsing giant cell arteritis.
    Oliveira F; Butendieck RR; Ginsburg WW; Parikh K; Abril A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S76-8. PubMed ID: 24854376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
    Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
    J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
    Yoshifuji H
    Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
    Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
    Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis.
    Conticini E; Sota J; Falsetti P; Baldi C; Bardelli M; Bellisai F; Tosi GM; Frediani B; Cantarini L
    Mediators Inflamm; 2020; 2020():3203241. PubMed ID: 33061825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab for the treatment of giant cell arteritis.
    Schirmer M; Muratore F; Salvarani C
    Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of tocilizumab for intractable Takayasu arteritis and
    Isobe M; Maejima Y; Saji M; Tateishi U
    J Cardiol; 2021 May; 77(5):539-544. PubMed ID: 33451862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
    Banerjee S; Quinn KA; Gribbons KB; Rosenblum JS; Civelek AC; Novakovich E; Merkel PA; Ahlman MA; Grayson PC
    J Rheumatol; 2020 Jan; 47(1):99-107. PubMed ID: 30877209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
    Decker P; Olivier P; Risse J; Zuily S; Wahl D
    Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
    Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
    J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool.
    Sebastian A; Kayani A; Prieto-Pena D; Tomelleri A; Whitlock M; Mo J; van der Geest N; Dasgupta B
    RMD Open; 2020 Nov; 6(3):. PubMed ID: 33161376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT.
    Henes JC; Mueller M; Pfannenberg C; Kanz L; Kötter I
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S43-8. PubMed ID: 21385544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.